TY - JOUR
T1 - n-Butanol fraction from Hedysarum alpinum L. attenuates scopolamine-induced memory impairment in rats
AU - Jalsrai, Aldarmaa
AU - Altangerel, Anu
AU - Urtnasan, Myadagbadam
AU - Borchuluun, Saranchimeg
AU - Battsogt, Kristina
AU - Cong, Yue
AU - Hsieh-Li, Hsiu Mei
N1 - Publisher Copyright:
Copyright © 2026 The Author(s).
PY - 2026/7
Y1 - 2026/7
N2 - Introduction: Hedysarum alpinum L. (HA) contains considerable amounts of polyphenols and saponins, and exhibits immune-enhancing and antiviral properties. Evidence indicates that triterpenoid saponins possess neuroprotective effects against neurodegenerative damage. The present study evaluated the effect of an HA saponin-rich n-butanol fraction (HABF) on cognitive deficits induced by scopolamine in a rat model. Methods: Cognitive impairment was assessed using passive avoidance (PA) and novel object recognition (NOR) tasks. Total triterpene saponins of HABF were quantified by the colorimetric method using oleanolic acid as a standard compound. Biochemical analyses of hippocampus tissue included measurements of acetylcholinesterase (AChE) activity, choline acetyltransferase (ChAT), catalase (CAT), and tumor necrosis factor-α (TNF-α). Results: HABF contained 131 ± 0.02 mg oleanolic acid equivalent (OAE)/g of total triterpene saponins. Scopolamine significantly impaired memory, as shown by a decreased discrimination index in the NOR test and reduced retention latency in the PA test. Pretreatment with HABF (40 and 80 mg/kg) significantly alleviated the memory deficits in both tasks. Scopolamine significantly increased AChE activity and TNF-α levels, and decreased CAT activity compared to the vehicle-treated group. These alterations were significantly reversed by HABF treatment, whereas ChAT activity remained unchanged compared with the MPTP-treated group. Conclusion: HABF, rich in triterpene saponins, ameliorates scopolamine-induced memory impairment, likely through the inhibition of AChE activity and modulation of oxidative stress and inflammation. These findings may suggest its potential neuroprotective effect in cognitive dysfunction.
AB - Introduction: Hedysarum alpinum L. (HA) contains considerable amounts of polyphenols and saponins, and exhibits immune-enhancing and antiviral properties. Evidence indicates that triterpenoid saponins possess neuroprotective effects against neurodegenerative damage. The present study evaluated the effect of an HA saponin-rich n-butanol fraction (HABF) on cognitive deficits induced by scopolamine in a rat model. Methods: Cognitive impairment was assessed using passive avoidance (PA) and novel object recognition (NOR) tasks. Total triterpene saponins of HABF were quantified by the colorimetric method using oleanolic acid as a standard compound. Biochemical analyses of hippocampus tissue included measurements of acetylcholinesterase (AChE) activity, choline acetyltransferase (ChAT), catalase (CAT), and tumor necrosis factor-α (TNF-α). Results: HABF contained 131 ± 0.02 mg oleanolic acid equivalent (OAE)/g of total triterpene saponins. Scopolamine significantly impaired memory, as shown by a decreased discrimination index in the NOR test and reduced retention latency in the PA test. Pretreatment with HABF (40 and 80 mg/kg) significantly alleviated the memory deficits in both tasks. Scopolamine significantly increased AChE activity and TNF-α levels, and decreased CAT activity compared to the vehicle-treated group. These alterations were significantly reversed by HABF treatment, whereas ChAT activity remained unchanged compared with the MPTP-treated group. Conclusion: HABF, rich in triterpene saponins, ameliorates scopolamine-induced memory impairment, likely through the inhibition of AChE activity and modulation of oxidative stress and inflammation. These findings may suggest its potential neuroprotective effect in cognitive dysfunction.
KW - Acetylcholinesterase
KW - Alzheimer’s disease
KW - Inf lammation
KW - Oxidative stress
KW - Triterpene saponins
UR - https://www.scopus.com/pages/publications/105044250993
UR - https://www.scopus.com/pages/publications/105044250993#tab=citedBy
U2 - 10.34172/jhp.53652
DO - 10.34172/jhp.53652
M3 - Article
AN - SCOPUS:105044250993
SN - 2345-5004
VL - 15
SP - 372
EP - 378
JO - Journal of HerbMed Pharmacology
JF - Journal of HerbMed Pharmacology
IS - 3
ER -